首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1659129

2025 年全球止血藥市場報告

Hemostats Global Market Report 2025

出版日期: 2025年02月18日 | 出版商:

The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年止血劑的市場規模將強勁成長。到 2029 年，這一數字將成長至 46.7 億美元，複合年成長率為 6.8%。預測期內的成長可歸因於緊急準備和大流行應對、全球醫療保健基礎設施的發展、對微創手術的需求不斷成長、各個專業的應用不斷擴大以及對生物相容性的重視。預測期內的主要趨勢包括產品創新、止血技術的進步以及對微創手術的關注。

預計外科手術的增加將推動止血材料市場未來的成長。外科手術是指對人體採取任何形式的侵入性治療，以檢查或治療病理狀況。止血鉗在外科手術過程中必不可少，因為它們用於防止手術期間出血。例如，根據總部位於黎巴嫩的整形外科醫生專業組織國際美容整形外科學會 2023 年 9 月的報告，2022 年整形外科醫生執行的手術總體成長了 11.2%，全球共執行了超過 1490 萬例手術和超過 1880 萬例非手術手術。此外，自上次調查以來，手術和非手術治療均有所增加（分別為 16.7% 和 7.2%）。因此，外科手術的增加正在推動止血材料市場的成長。

由於政府推出免費手術的舉措，止血材料市場預計將進一步成長。免費手術不向患者收取任何費用，減輕了經濟困難患者的治療負擔。根據 PubMed 2022 年 5 月的一篇報導報道，在印度各地三級醫院進行的一項研究顯示了顯著的影響。約41.7%的受訪者平等地進行了腹腔鏡和開放性手術，展示了止血材料的多樣化應用。手術需求的激增，尤其是止血材料使用的趨勢，凸顯了政府措施在推動止血材料市場成長方面的關鍵作用。

全球止血劑市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
最終用途產業分析
全球止血劑市場：成長率分析
全球止血劑市場表現：規模與成長，2019 年至 2024 年
全球止血劑市場預測：2024-2029 年、2034 年規模與成長
止血鉗的全球總潛在市場 (TAM)

第6章市場細分

全球止血劑市場類型、性能及預測，2019-2024、2024-2029、2034
凝血酶類止血劑
氧化再生纖維素基止血劑
複合止血鉗
明膠基止血材料
膠原蛋白基止血材料
全球止血劑市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
主動止血劑
被動止血
複合止血鉗
其他產品
全球止血劑市場：按配方、性能和預測，2019-2024 年、2024-2029 年、2034 年
基質和凝膠止血劑
止血片和墊片
海綿止血材料
粉末止血劑
全球止血劑市場應用、效能及預測，2019-2024、2024-2029、2034
整形外科
一般外科
神經外科
心血管外科
重組手術
婦科手術
其他用途
全球止血劑市場：凝血酶類止血劑按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
局部凝血酶
冷凍乾燥凝血酶
全球止血劑市場：氧化再生纖維素止血劑按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
墊片
顆粒
全球止血劑市場：複合止血劑按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
凝血酶-明膠複合物
凝血酶-膠原蛋白複合物
全球止血劑市場：明膠基止血劑按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
凝膠泡沫
明膠海綿
全球止血劑市場：膠原蛋白蛋白止血劑按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
膠原蛋白蛋白片
膠原蛋白蛋白粉

第7章區域和國家分析

全球止血劑市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球止血劑市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第 17 章德國市場

第 18 章法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第 25 章：加拿大市場

第26章南美洲市場

第 27 章：巴西市場

第28章中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

止血劑市場：競爭格局
止血劑市場：公司簡介
- B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
- Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis
- Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

Medtronic PLC
Hemostasis LLC
Stryker Corporation
Advanced Medical Solutions Group PLC
Samyang Holdings Corporation
Gelita Medical GmbH
CryoLife Inc.
CuraMedical BV
Meril Life Sciences Pvt. Ltd.
Beijing Datsing Bio-Tech Co. Ltd.
Zhonghui Shengxi（Beijing）Medical Technology Co. Ltd.
Biotemed Inc.
Biom'up SA
Shandong Foryou Medical Devices Co. Ltd.
Z-Medica LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第 34 章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

2029 年止血材料市場：提供新機會的國家
2029 年止血藥市場：細分市場將帶來新機會
止血劑市場 2029：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第 36 章附錄

簡介目錄

Product Code: r22670

A hemostat is a surgical tool employed in various surgical procedures to control or compress bleeding vessels, facilitating the treatment of wounds and aiding in visualizing deeper regions during surgeries.

There are several types of hemostats, including thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used to control and reduce blood loss during surgical procedures, either in conjunction with or as an alternative to traditional surgical techniques. Thrombin is an enzyme that breaks down fibrinogen into fibrin, promoting blood clotting. Examples of active hemostats include topical (bovine) thrombin (Thrombin-JMI), topical (human) thrombin (Evithrom), and topical (recombinant) thrombin (Recothrom). They are available in various forms, such as active hemostats, passive hemostats, combination hemostats, and others. Formulations include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. These hemostats find applications in orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other medical procedures.

The hemostats market research report is one of a series of new reports from The Business Research Company that provides hemostats market statistics, including hemostats industry global market size, regional shares, competitors with a hemostats market share, detailed hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. This hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications.

The hemostats market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to emergency preparedness and pandemic response, global healthcare infrastructure development, growing demand for minimally invasive surgeries, expanding applications in various specialties, focus on biocompatibility. Major trends in the forecast period include product innovations, advancements in hemostatic technologies, focus on minimally invasive surgeries.

An increase in surgical procedures is expected to propel the growth of the hemostat market going forward. Surgical procedures refer to all forms of invasive treatments that are used on a person to investigate or treat a pathological condition. Hemostats are essential for surgical procedures as they are used to prevent blood loss while performing surgery. For instance, in September 2023, according to the International Society of Aesthetic Plastic Surgery, a Lebanon-based professional organization for board-certified plastic surgeons, there was an 11.2% overall increase in procedures performed by plastic surgeons in 2022, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Additionally, both surgical and non-surgical procedures showed increases since the last survey (16.7% and 7.2% respectively). Therefore, an increase in surgical procedures is driving the growth of the hemostat market.

The hemostat market is poised for further growth, driven by government initiatives aimed at providing free surgeries. Free surgeries, performed without charging patients, alleviate the treatment burden on the economically disadvantaged. A survey conducted in tertiary care hospitals across India, as reported in a May 2022 article on PubMed, revealed a significant impact. Approximately 41.7% of respondents performed both laparoscopic and open procedures equally, demonstrating the diverse application of hemostats. The surge in surgical demand, especially with the trend toward hemostat usage, emphasizes the pivotal role of government initiatives in propelling the hemostat market's growth.

Technological advancement emerges as a key trend shaping the hemostat market, with major companies investing in new technologies and research and development efforts. Baxter, a prominent US-based healthcare company, exemplifies this trend through the launch of PERCLOT Absorbable Hemostatic Powder in March 2022. This passive, absorbable hemostatic powder is designed for patients with intact coagulation to address mild bleeding, providing surgeons with a versatile tool for bleeding control. The emphasis on technological innovation highlights the commitment to optimizing patient care and expanding the range of hemostatic solutions.

Major companies in the hemostat market are strategically engaging in partnerships and collaborations, particularly with start-ups and mid-sized companies, to enhance their product and service offerings. In May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, expanded its partnership with Endoclot, a US-based medical device company. This collaboration aims to launch hemostatic agents, contributing to safe treatment in gastrointestinal procedures. By entering strategic partnerships, companies like Olympus seek to broaden their product portfolios and geographical reach, ultimately elevating the standard of care and improving patient outcomes in the hemostat market.

In December 2022, Integra LifeSciences, a US-based medical technology company, acquired Surgical Innovation Associates for $150 million. This acquisition allows Integra LifeSciences Holding Corporation to enhance its product portfolio, expand its market reach, and strengthen its position in the medical technology sector. Surgical Innovation Associates is a US-based company specializing in providing advanced surgical technologies and solutions.

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Thrombin-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Combination Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats
2) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
3) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats
4) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
Subsegments:
1) By Thrombin-Based Hemostats: Topical Thrombin; Lyophilized Thrombin
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads; Granules
3) By Combination Hemostats: Thrombin And Gelatin Combinations; Thrombin And Collagen Combinations
4) By Gelatin-Based Hemostats: Gelfoam; Gelatin Sponge
5) By Collagen-Based Hemostats: Collagen Sheets; Collagen Powder
Companies Mentioned: B. Braun Melsungen AG; Baxter International Inc.; Integra LifeSciences Corporation; Becton Dickinson and Company; Teleflex Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Hemostats Market Characteristics

3. Hemostats Market Trends And Strategies

4. Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hemostats Growth Analysis And Strategic Analysis Framework

5.1. Global Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hemostats Market Growth Rate Analysis
5.4. Global Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hemostats Total Addressable Market (TAM)

6. Hemostats Market Segmentation

6.1. Global Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose-Based Hemostats
Combination Hemostats
Gelatin-Based Hemostats
Collagen-Based Hemostats
6.2. Global Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Active Hemostats
Passive Hemostats
Combination Hemostats
Other Product
6.3. Global Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Matrix And Gel Hemostats
Sheet And Pad Hemostats
Sponge Hemostats
Powder Hemostats
6.4. Global Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Other Applications
6.5. Global Hemostats Market, Sub-Segmentation Of Thrombin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Thrombin
Lyophilized Thrombin
6.6. Global Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pads
Granules
6.7. Global Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thrombin And Gelatin Combinations
Thrombin And Collagen Combinations
6.8. Global Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gelfoam
Gelatin Sponge
6.9. Global Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Collagen Sheets
Collagen Powder

7. Hemostats Market Regional And Country Analysis

7.1. Global Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemostats Market

8.1. Asia-Pacific Hemostats Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemostats Market

9.1. China Hemostats Market Overview
9.2. China Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemostats Market

10.1. India Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemostats Market

11.1. Japan Hemostats Market Overview
11.2. Japan Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemostats Market

12.1. Australia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemostats Market

13.1. Indonesia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemostats Market

14.1. South Korea Hemostats Market Overview
14.2. South Korea Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemostats Market

15.1. Western Europe Hemostats Market Overview
15.2. Western Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemostats Market

16.1. UK Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemostats Market

17.1. Germany Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemostats Market

18.1. France Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemostats Market

19.1. Italy Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemostats Market

20.1. Spain Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemostats Market

21.1. Eastern Europe Hemostats Market Overview
21.2. Eastern Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemostats Market

22.1. Russia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemostats Market

23.1. North America Hemostats Market Overview
23.2. North America Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemostats Market

24.1. USA Hemostats Market Overview
24.2. USA Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemostats Market

25.1. Canada Hemostats Market Overview
25.2. Canada Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemostats Market

26.1. South America Hemostats Market Overview
26.2. South America Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemostats Market

27.1. Brazil Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemostats Market

28.1. Middle East Hemostats Market Overview
28.2. Middle East Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemostats Market

29.1. Africa Hemostats Market Overview
29.2. Africa Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemostats Market Competitive Landscape And Company Profiles

30.1. Hemostats Market Competitive Landscape
30.2. Hemostats Market Company Profiles
- 30.2.1. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Hemostats Market Other Major And Innovative Companies

31.1. Medtronic PLC
31.2. Hemostasis LLC
31.3. Stryker Corporation
31.4. Advanced Medical Solutions Group PLC
31.5. Samyang Holdings Corporation
31.6. Gelita Medical GmbH
31.7. CryoLife Inc.
31.8. CuraMedical B.V.
31.9. Meril Life Sciences Pvt. Ltd.
31.10. Beijing Datsing Bio-Tech Co. Ltd.
31.11. Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd.
31.12. Biotemed Inc.
31.13. Biom'up SA
31.14. Shandong Foryou Medical Devices Co. Ltd.
31.15. Z-Medica LLC

32. Global Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostats Market

34. Recent Developments In The Hemostats Market

35. Hemostats Market High Potential Countries, Segments and Strategies

35.1 Hemostats Market In 2029 - Countries Offering Most New Opportunities
35.2 Hemostats Market In 2029 - Segments Offering Most New Opportunities
35.3 Hemostats Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies